Edwards Lifesciences Corp
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement prod… Read more
Edwards Lifesciences Corp (EW) - Total Liabilities
Latest total liabilities as of September 2025: $3.07 Billion USD
Based on the latest financial reports, Edwards Lifesciences Corp (EW) has total liabilities worth $3.07 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Edwards Lifesciences Corp - Total Liabilities Trend (1999–2024)
This chart illustrates how Edwards Lifesciences Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Edwards Lifesciences Corp Competitors by Total Liabilities
The table below lists competitors of Edwards Lifesciences Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ciena Corp
NYSE:CIEN
|
USA | $3.10 Billion |
|
Malayan Banking Berhad
PINK:MLYBY
|
USA | $956.30 Billion |
|
Electronic Arts Inc
NASDAQ:EA
|
USA | $7.13 Billion |
|
Coinbase Global Inc
NASDAQ:COIN
|
USA | $14.88 Billion |
|
China Hongqiao Group Limited
PINK:CHHQY
|
USA | $112.14 Billion |
|
Yum! Brands Inc
NYSE:YUM
|
USA | $15.52 Billion |
|
Chipotle Mexican Grill Inc
NYSE:CMG
|
USA | $6.16 Billion |
|
Deutsche Börse AG
PINK:DBOEF
|
USA | $283.25 Billion |
Liability Composition Analysis (1999–2024)
This chart breaks down Edwards Lifesciences Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 1.69 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Edwards Lifesciences Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Edwards Lifesciences Corp (1999–2024)
The table below shows the annual total liabilities of Edwards Lifesciences Corp from 1999 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $2.99 Billion | +13.19% |
| 2023-12-31 | $2.64 Billion | +6.36% |
| 2022-12-31 | $2.49 Billion | -6.78% |
| 2021-12-31 | $2.67 Billion | +0.15% |
| 2020-12-31 | $2.66 Billion | +13.80% |
| 2019-12-31 | $2.34 Billion | +7.17% |
| 2018-12-31 | $2.18 Billion | -19.19% |
| 2017-12-31 | $2.70 Billion | +42.88% |
| 2016-12-31 | $1.89 Billion | +21.51% |
| 2015-12-31 | $1.56 Billion | +16.75% |
| 2014-12-31 | $1.33 Billion | +14.36% |
| 2013-12-31 | $1.17 Billion | +57.03% |
| 2012-12-31 | $742.20 Million | +15.50% |
| 2011-12-31 | $642.60 Million | +40.00% |
| 2010-12-31 | $459.00 Million | +0.31% |
| 2009-12-31 | $457.60 Million | -12.24% |
| 2008-12-31 | $521.40 Million | +2.22% |
| 2007-12-31 | $510.10 Million | +2.55% |
| 2006-12-31 | $497.40 Million | -7.74% |
| 2005-12-31 | $539.10 Million | +11.25% |
| 2004-12-31 | $484.60 Million | +3.92% |
| 2003-12-31 | $466.30 Million | -0.53% |
| 2002-12-31 | $468.80 Million | -8.79% |
| 2001-12-31 | $514.00 Million | -20.68% |
| 2000-12-31 | $648.00 Million | +204.23% |
| 1999-12-31 | $213.00 Million | -- |